Gain Therapeutics, Inc.
Nasdaq GANX · Bethesda, MD
Works in Neurology
Gain Therapeutics, Inc. is a clinical trial sponsor based in Bethesda, MD, listed as Nasdaq GANX. It has 2 active clinical trials with 131 planned participants, in Neurology.
Trial track record · since 2021
Financials · Nasdaq GANX
Fundraising
Pipeline · 2 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Gain Therapeutics, Inc
Gain Therapeutics, Inc is lead sponsor of 2 active clinical trials on ClinicalTrials.gov, with 131 planned participants, in Neurology. Since 2021 it has completed 0 trials and stopped 0 early.
Gain Therapeutics, Inc is based in Bethesda, MD and is listed as Nasdaq GANX. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Gain Therapeutics, Inc; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2025-12-12.
Approve Suite is not affiliated with Gain Therapeutics, Inc..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.